Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

The ARIA-MASK study group, Ludger Klimek, Marek Jutel, Cezmi Akdis, Tari Haahtela, Sanna Toppila-Salmi

Research output: Contribution to journalArticleScientificpeer-review


ABSTRACT The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient
Original languageEnglish
JournalAllergy : European journal of allergy and clinical immunology
Publication statusE-pub ahead of print - 24 Apr 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3121 Internal medicine

Cite this